IBA Proton Therapy

We look forward to seeing Southwest Florida Proton start treating patients and benefiting from all the advantages of the ProteusONE. Thank you for your trust. We are honored to work with you in the fight against cancer. #KeepEverythingButCancer

Don’t miss Apollo Proton Cancer Centre’s study: “Influence of Spatial Redistribution of Heterogeneities in Proton Beam Characteristics,” published in Physica Medica. This research explores the critical effects of spatially distributed heterogeneous materials on proton pencil beam scanning.

🗓️ Don't miss this year's International Symposium on Proton Therapy! April 25-26 | Philadelphia, PA This premier event, co-chaired by experts Dr. James Metz and Dr. Jeff Bradley from Penn Medicine Radiation Oncology, will feature presentations by leading voices in proton therapy, interactive discussions amongst peers, and social events designed to foster networking and collaboration. Learn more and register today ➡️ https://lnkd.in/gBXTxVXt

Congratulations to MedAustron for the first proton treatment of uveal melanoma in Austria. This achievement enables high-precision treatments while protecting sensitive structures – a tremendous advantage for patients.

🎉Congratulations to The University of Kansas Cancer Center for this fantastic milestone of treating 500 patients with proton therapy. A big shoutout to the entire team for their hard work and commitment to improving patient outcomes. 👏 Together, we are making a significant impact in the fight against cancer.

𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝘆𝗼𝘂𝗿 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗮𝘁𝘁𝗿𝗮𝗰𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 and increase both patient referrals and new patient start volumes by offering proton therapy with ProteusONE. Learn about the proton therapy halo effect ➡️https://lnkd.in/eWmaEfbh #CancerTreatment #ProtonTherapy #ProteusONE #IBATechnology #HealthcareInnovation #Oncology #radiationoncology #keepeverythingbutcancer #IBA #patientexperience #cancerpatient #haloeffect

We are proud to announce our partnership with JEMA, a subsidiary of CE+T Group, renowned for designing high-performance power solutions and RF amplifiers for global markets. With the unwavering support of JEMA and CE+T, we are committed to transforming the cancer journey with a focus on a human-centered approach. Our shared goal is to ensure that cancer patients receive the care and assistance they need at every stage, by supporting the global development of integrative health centers. Many thanks to Nicolas Bronchart, Robert Eyben, Ben Hayen, Jean Crahay, Rudy Kersten, and Claude Grégoire for their trust and commitment to our cause. As JEMA SA, we invite you to join us in making a meaningful impact by humanizing cancer care. #Partnerships #CancerPatient #HealthcareInnovations #LifeWithPurpose

Join us at the Middle East Federation of Organizations of Medical Physics (MEFOMP) 📅 February 8-10, 2025 📍Kuwait Cancer Control Center, Ministry Of Health , Kuwait Our team of specialists will be there to share groundbreaking research, showcase our latest proton therapy solutions, and explore new avenues for collaboration. Visit our booth and join us for an exclusive session on the future of proton therapy in cancer treatment. Stay tuned as we’ll soon share more details about our participation in MEFOMP 🚀

We are thrilled to announce that Peter Johnstone, MD will be recognized with the prestigious Gold Medal Award at the upcoming 107th ARS Annual Meeting. This honor celebrates Dr. Johnstone’s extraordinary contributions to the field of oncology and his unwavering commitment to advancing cancer care. Stay tuned for updates, and join us in celebrating this remarkable milestone for Dr. Johnstone! 

𝗖𝗼𝘂𝗹𝗱 𝘄𝗲 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝗽𝘂𝘁 𝗶𝗻 𝗣𝗿𝗼𝘁𝗼𝗻 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗲𝗻𝘁𝗲𝗿𝘀? Dr. Craig W. Stevens from William Beaumont University Hospital explains how IBA’s unique DynamicARC®* has the potential to revolutionize proton therapy by sharper, faster and simpler treatments. This groundbreaking treatment modality allows simultaneous dynamic beam delivery at variable energies while the gantry rotates, enabling faster treatment. According to Dr. Stevens, this could increase the number of patients treated per day by 30%. Watch the video to learn why DynamicARC will probably become the leading form of IMPT, just like VMAT with X-rays: https://lnkd.in/eYN2XUDu #ProtonTherapy #arctherapy #DynamicARC #CancerTreatment #RadiationOncology #ProteusONE Disclaimer: The statements of the healthcare professional included in this testimonial reflect only his opinion and personal experience. They do not necessarily reflect the opinion of any institution with whom he is affiliated or IBA. * DynamicARC® is the registered brand of IBA’s Proton Arc therapy solution which is currently under research and development. DynamicARC® will be available for sale when regulatory clearance is received. Due to a continuous research and development program, IBA reserves the right to make changes in design, technical descriptions, and specifications of its products without prior notice. Some features are under development and may be subject to review by competent authorities.